Anebulo Pharmaceuticals, Inc. (ANEB)
OTCMKTS · Delayed Price · Currency is USD
0.3300
0.00 (0.00%)
Jul 28, 2026, 9:32 AM EST
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $13.46 million as of July 28, 2026. Its market cap has decreased by -89.73% in one year.
Market Cap
13.46M
Enterprise Value
4.42M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.33
ChartMarket Cap Chart
Since May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from 165.19M to 13.46M, a decrease of -91.85%. That is a compound annual growth rate of -38.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 13.46M | -67.57% |
| Dec 31, 2025 | 41.50M | -4.76% |
| Dec 31, 2024 | 43.57M | -29.77% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -13.09% |
| May 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galera Therapeutics | 18.20M |
| Finch Therapeutics Group | 16.06M |
| Oncotelic Therapeutics | 15.96M |
| Inhibitor Therapeutics | 15.07M |
| Zeo ScientifiX | 12.93M |
| Brainstorm Cell Therapeutics | 10.59M |
| Zenith Capital | 7.99M |
| NKGen Biotech | 7.84M |